Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
Roberto Maggio, Giovanni Corsini
Topics & Concepts
RepurposingTMPRSS2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Protease inhibitor (pharmacology)MedicineCoronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakDrug repositioningVirologyProteaseMicrobiologyPharmacologyVirusChemistryInternal medicineBiologyViral loadDrugEnzymeOutbreakDiseaseBiochemistryAntiretroviral therapyInfectious disease (medical specialty)EcologyRespiratory and Cough-Related ResearchPneumonia and Respiratory InfectionsRespiratory viral infections research